Delivery Order SPE2DB24D2011-SPE2DB25FBRPY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,764.33 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of FORTEO 560 MCG/2.24 ML pen injections. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,057.77 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.76 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injection) with a ceiling value of $8,274.44. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $12,499.08 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 ml pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is an FDA-approved pharmaceutical treatment for osteoporosis and bone-related conditions, commonly utilized within military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRPYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,993.09 to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 micrograms per 2.24 milliliters pen injections on August 19, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime contract vehicle designated SPE2DX and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical deliveries to DLA and military healthcare systems. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies supporting the Defense Health Agency and other government healthcare systems. The current delivery order for FORTEO, a bone-building medication, exemplifies the contractor's role in supplying specialized pharmaceuticals to military and veteran healthcare programs through the comprehensive DLA global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.0k | 8/19/25 |